Back to Search

MERRY TETEF, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1194784785Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

G64196(CA)

Research & Publications (13)

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
PMID 11410492·Clin Cancer Res·2001
3-trial
Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.
PMID 10912573·Cancer Chemother Pharmacol·2000
3-trial
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
PMID 19307510·J Clin Oncol·2009
3-trial
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
PMID 17317834·Clin Cancer Res·2007
3-trial
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.
PMID 15256240·Eur J Surg Oncol·2004
8-other
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
PMID 15184995·Cancer Chemother Pharmacol·2004
3-trial
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
PMID 15173955·Cancer Chemother Pharmacol·2004
3-trial
Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies.
PMID 12695856·Cancer Chemother Pharmacol·2003
3-trial
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
PMID 11401310·Br J Cancer·2001
3-trial
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies.
PMID 11400951·Biol Blood Marrow Transplant·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
24302 PASEO DE VALENCIA STE 200
LAGUNA HILLS, CA 92653

Quick Facts

NPI
1194784785
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
13

Are you this provider?

Claim Your Profile